AR and colorectal carcinoma: In another study, the combination of selective androgen receptor modulator (SARM), GTx-024, with histone deacetylase inhibitor (HDACi), AR-42, was found to improve anabolic response in the cachectic condition in CRC by mediating the regulation of β-catenin in C-26 cachectic mice model [142].